Longevity hope: Doctor’s Best new NMN product achieved US$1m mark in China
A nicotinamide mononucleotide (NMN) supplement made by US supplement firm Doctor’s Best hit the US$1m sales in the first 10 days of its launch in China.
Over 5,000 bottles had been sold on its Tmall flagship store in July, its parent company Xiamen Kingdomway Group said.
Following the sold-out of the initial batch of 1,406 bottles, subsequent pre-orders of 3,605 bottles were received within three days between July 16 and 19.
Together, the product had brought in sales amounted to RMB$7.68m (US$1m).
